<p>2025 年 9 月 4 日- 下午 12:07</p>
<p>佛罗里达州那不勒斯，2025 年 9 月 4 日（GLOBE NEWSWIRE）-- 通过 IBN -- HealthLynked Corp.（OTCQB:HLYK）-- 尊敬的股东，</p>
<p>我写信是为了分享 HealthLynked Corp.持续发展的重要更新，这反映了我们对长期增长和增强股东价值的承诺。</p>
<p>我们已完成对流通股数量的战略性减少。这一举措——通常称为反向股票拆分——是加强我们资本结构、改善市场定位以及使 HealthLynked 与机构投资者和国家交易平台的期望保持一致的更广泛努力的一部分。</p>
<p>这为什么重要</p>
<p>通过减少流通股数量，我们提高了每股价格，而不影响您在公司的持股比例。这是一个非稀释性的步骤，有助于提高可见度、潜在的上市机会，并接触到更广泛的投资者，包括那些使用需要最低股价参与的交易平台的投资者。</p>
<p>这种方法已被许多准备在更大市场上占有一席之地的新兴成长公司成功采用，我们相信这将使 HealthLynked 走上类似的道路。</p>
<p>为增长而生，准备扩展</p>
<p>我们最近推出了专利的人工智能医疗指南 ARi，并通过我们的全国远程医疗平台和其他数字服务继续建立商业吸引力。尽管在收入生成方面仍处于早期阶段，但这些平台正在获得动力，并为可扩展部署做好准备。</p>
<p>我们目前正在与主要保险公司讨论将我们的技术整合到护理管理工作流程中——这一模式可能会在大规模会员群体中推动可观的经常性收入。同时，我们正在扩展我们的知识产权组合，基于我们在医疗和人工智能领域的现有专利，支持未来的创新和可防御的市场领导地位。</p>
<p>展望未来</p>
<p>减少流通股数量只是增强股东价值、吸引机构支持和扩展我们运营的更大计划中的一步。我们的愿景宏伟，我们的技术旨在产生影响。我们将继续专注于执行这一愿景，同时将股东的长期利益放在首位。</p>
<p>感谢您持续的信任和支持。我们期待在未来几个月与您分享更多进展。</p>
<p>诚挚的，</p>
<p><strong>Michael Dent M.D.</strong></p>
<p>首席执行官</p>
<p>HealthLynked Corp.</p>
<p><strong>关于 HealthLynked Corp</strong></p>
<p>HealthLynked Corp.通过个性化的护理管理提升医疗保健，改善结果并降低成本。其基于云的平台将患者与提供者连接，以进行虚拟或面对面的预约，并将医疗记录整合到一个安全、可访问的位置。</p>
<p>凭借人工智能驱动的洞察和集成的远程医疗服务，HealthLynked 使患者和提供者能够更有效地协调护理，同时在处方和医疗服务上提供可观的节省。该平台支持企业合作伙伴关系，为医疗网络和数字健康创新者提供可扩展的解决方案。</p>
<p>了解更多信息：www.hlykgroup.com</p>
<p><strong>下载 HealthLynked 应用程序：</strong></p>
<ul>
<li>苹果应用商店</li>
<li>谷歌 Play 商店</li>
</ul>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含根据 1995 年《私人证券诉讼改革法》定义的前瞻性声明。这些声明本质上是不确定的，可能与实际结果有重大差异。前瞻性声明反映了管理层当前的期望，并受到风险、不确定性和假设的影响。HealthLynked 不承担更新这些声明的义务，除非法律要求。</p>
<p><strong>投资者与媒体联系</strong></p>
<p>HealthLynked Corp.</p>
<p>1265 Creekside Parkway, Suite 200</p>
<p>那不勒斯，FL 34108</p>
<p>电话：+1 (800) 928-7144</p>
<p>电子邮件：IR@healthlynked.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeU16VTNOaU0zTVRNeE1UTTNJelV3TURFeU1UVTVOUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeU16VTNOaU0zTVRNeE1UTTNJelV3TURFeU1UVTVOUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/YTRmODU5ZWYtNjUyMS00NjI1LWEzMGMtZTRjMzI3YjZjMTgwLTUwMDEyMTU5NS0yMDI1LTA5LTA0LWVu/tiny/HealthLynked-Corp.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/YTRmODU5ZWYtNjUyMS00NjI1LWEzMGMtZTRjMzI3YjZjMTgwLTUwMDEyMTU5NS0yMDI1LTA5LTA0LWVu/tiny/HealthLynked-Corp.png"/></p>

HLYK

HLYKD

<p>HealthLynked Corp. 已完成反向股票拆分，以增强其市场地位并提升股东价值。这一战略举措旨在改善资本结构，并通过提高每股价格而不稀释股权来吸引机构投资者。该公司还在扩大其基于人工智能的医疗保健平台，并扩展其知识产权组合。首席执行官迈克尔·登特强调了对长期增长的承诺，以及通过与主要保险公司合作实现可观的经常性收入的潜力</p>

<p>09/04/2025 - 12:07 PM</p>
<div class="lb-trans"><p>2025 年 9 月 4 日- 下午 12:07</p>
</div><p>NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB:HLYK) -- Dear Shareholders,</p>
<div class="lb-trans"><p>佛罗里达州那不勒斯，2025 年 9 月 4 日（GLOBE NEWSWIRE）-- 通过 IBN -- HealthLynked Corp.（OTCQB:HLYK）-- 尊敬的股东，</p>
</div><p>I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth and enhanced shareholder value.</p>
<div class="lb-trans"><p>我写信是为了分享 HealthLynked Corp.持续发展的重要更新，这反映了我们对长期增长和增强股东价值的承诺。</p>
</div><p>We've completed a strategic reduction in the number of our outstanding shares. This move—commonly referred to as a reverse stock split—is part of a broader effort to strengthen our capital structure, improve our market positioning, and align HealthLynked with the expectations of institutional investors and national trading platforms.</p>
<div class="lb-trans"><p>我们已完成对流通股数量的战略性减少。这一举措——通常称为反向股票拆分——是加强我们资本结构、改善市场定位以及使 HealthLynked 与机构投资者和国家交易平台的期望保持一致的更广泛努力的一部分。</p>
</div><p>Why This Matters</p>
<div class="lb-trans"><p>这为什么重要</p>
</div><p>By reducing the number of shares outstanding, we've increased our per-share price without impacting your percentage ownership in the Company. This is a non-dilutive step that supports greater visibility, potential uplisting opportunities, and access to a broader range of investors—including those using trading platforms that require a minimum share price for participation.</p>
<div class="lb-trans"><p>通过减少流通股数量，我们提高了每股价格，而不影响您在公司的持股比例。这是一个非稀释性的步骤，有助于提高可见度、潜在的上市机会，并接触到更广泛的投资者，包括那些使用需要最低股价参与的交易平台的投资者。</p>
</div><p>This approach has been used successfully by many emerging growth companies preparing for a larger market presence, and we believe it puts HealthLynked on a similar path.</p>
<div class="lb-trans"><p>这种方法已被许多准备在更大市场上占有一席之地的新兴成长公司成功采用，我们相信这将使 HealthLynked 走上类似的道路。</p>
</div><p>Built for Growth, Ready to Scale</p>
<div class="lb-trans"><p>为增长而生，准备扩展</p>
</div><p>We've recently launched our patented AI healthcare guide, ARi, and we continue to build commercial traction through our nationwide telemedicine platform and other digital services. While early in revenue generation, these platforms are gaining momentum and positioning us for scalable deployment.</p>
<div class="lb-trans"><p>我们最近推出了专利的人工智能医疗指南 ARi，并通过我们的全国远程医疗平台和其他数字服务继续建立商业吸引力。尽管在收入生成方面仍处于早期阶段，但这些平台正在获得动力，并为可扩展部署做好准备。</p>
</div><p>We are currently in discussions with major insurance carriers to integrate our technology into care management workflows—a model that could drive substantial recurring revenue across large member populations. At the same time, we are expanding our intellectual property portfolio, building on our existing patents in healthcare and AI to support future innovation and defensible market leadership.</p>
<div class="lb-trans"><p>我们目前正在与主要保险公司讨论将我们的技术整合到护理管理工作流程中——这一模式可能会在大规模会员群体中推动可观的经常性收入。同时，我们正在扩展我们的知识产权组合，基于我们在医疗和人工智能领域的现有专利，支持未来的创新和可防御的市场领导地位。</p>
</div><p>Looking Ahead</p>
<div class="lb-trans"><p>展望未来</p>
</div><p>The reduction in our outstanding shares is just one step in a larger plan to enhance shareholder value, attract institutional support, and scale our operations. Our vision is bold, and our technology is built for impact. We remain focused on executing that vision while keeping the long-term interests of our shareholders front and center.</p>
<div class="lb-trans"><p>减少流通股数量只是增强股东价值、吸引机构支持和扩展我们运营的更大计划中的一步。我们的愿景宏伟，我们的技术旨在产生影响。我们将继续专注于执行这一愿景，同时将股东的长期利益放在首位。</p>
</div><p>Thank you for your continued trust and support. We look forward to sharing more progress with you in the months ahead.</p>
<div class="lb-trans"><p>感谢您持续的信任和支持。我们期待在未来几个月与您分享更多进展。</p>
</div><p>Sincerely,</p>
<div class="lb-trans"><p>诚挚的，</p>
</div><p><strong>Michael Dent M.D.</strong></p>
<div class="lb-trans"><p><strong>Michael Dent M.D.</strong></p>
</div><p>Chief Executive Officer</p>
<div class="lb-trans"><p>首席执行官</p>
</div><p>HealthLynked Corp.</p>
<div class="lb-trans"><p>HealthLynked Corp.</p>
</div><p><strong>About HealthLynked Corp</strong></p>
<div class="lb-trans"><p><strong>关于 HealthLynked Corp</strong></p>
</div><p>HealthLynked Corp. enhances healthcare through personalized care management that improves outcomes and reduces costs. Its cloud-based platform connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location.</p>
<div class="lb-trans"><p>HealthLynked Corp.通过个性化的护理管理提升医疗保健，改善结果并降低成本。其基于云的平台将患者与提供者连接，以进行虚拟或面对面的预约，并将医疗记录整合到一个安全、可访问的位置。</p>
</div><p>With AI-driven insights and integrated telehealth services, HealthLynked empowers patients and providers to coordinate care more effectively, while delivering substantial savings on prescriptions and healthcare services. The platform supports enterprise partnerships, offering scalable solutions to healthcare networks and digital health innovators.</p>
<div class="lb-trans"><p>凭借人工智能驱动的洞察和集成的远程医疗服务，HealthLynked 使患者和提供者能够更有效地协调护理，同时在处方和医疗服务上提供可观的节省。该平台支持企业合作伙伴关系，为医疗网络和数字健康创新者提供可扩展的解决方案。</p>
</div><p>Learn more at:www.hlykgroup.com</p>
<div class="lb-trans"><p>了解更多信息：www.hlykgroup.com</p>
</div><p><strong>Download the HealthLynked App:</strong></p>
<div class="lb-trans"><p><strong>下载 HealthLynked 应用程序：</strong></p>
</div><ul>
<li>Apple App Store</li>
<li>Google Play Store</li>
</ul>
<div class="lb-trans"><ul>
<li>苹果应用商店</li>
<li>谷歌 Play 商店</li>
</ul>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such statements are inherently uncertain and may differ materially from actual results. Forward-looking statements reflect management's current expectations and are subject to risks, uncertainties, and assumptions. HealthLynked disclaims any obligation to update these statements except as required by law.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1995 年《私人证券诉讼改革法》定义的前瞻性声明。这些声明本质上是不确定的，可能与实际结果有重大差异。前瞻性声明反映了管理层当前的期望，并受到风险、不确定性和假设的影响。HealthLynked 不承担更新这些声明的义务，除非法律要求。</p>
</div><p><strong>Investor &amp; Media Contact</strong></p>
<div class="lb-trans"><p><strong>投资者与媒体联系</strong></p>
</div><p>HealthLynked Corp.</p>
<div class="lb-trans"><p>HealthLynked Corp.</p>
</div><p>1265 Creekside Parkway, Suite 200</p>
<div class="lb-trans"><p>1265 Creekside Parkway, Suite 200</p>
</div><p>Naples, FL 34108</p>
<div class="lb-trans"><p>那不勒斯，FL 34108</p>
</div><p>Phone: +1 (800) 928-7144</p>
<div class="lb-trans"><p>电话：+1 (800) 928-7144</p>
</div><p>Email:IR@healthlynked.com</p>
<div class="lb-trans"><p>电子邮件：IR@healthlynked.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RVeU16VTNOaU0zTVRNeE1UTTNJelV3TURFeU1UVTVOUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTUyMzU3NiM3MTMxMTM3IzUwMDEyMTU5NQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/YTRmODU5ZWYtNjUyMS00NjI1LWEzMGMtZTRjMzI3YjZjMTgwLTUwMDEyMTU5NS0yMDI1LTA5LTA0LWVu/tiny/HealthLynked-Corp.png" alt="" original-src="https://ml.globenewswire.com/media/YTRmODU5ZWYtNjUyMS00NjI1LWEzMGMtZTRjMzI3YjZjMTgwLTUwMDEyMTU5NS0yMDI1LTA5LTA0LWVu/tiny/HealthLynked-Corp.png"/></p>

反向股票拆分增强了 HealthLynked 的市场地位，随着公司扩展其 AI 驱动的医疗平台 | HLYK 股票新闻